Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.3888
-0.0011 (-0.28%)
Sep 12, 2025, 4:00 PM EDT - Market closed
Vaxart Market Cap
Vaxart has a market cap or net worth of $88.82 million as of September 12, 2025. Its market cap has decreased by -56.03% in one year.
Market Cap
88.82M
Enterprise Value
81.84M
1-Year Change
-56.03%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from $60.35M to $88.82M, an increase of 47.17%. That is a compound annual growth rate of 5.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 89.09M | -40.85% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | 625.07M | 3,636.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |